States rebuke drugmakers’ call for “gag order”
States alleging an overarching price-fixing conspiracy in the generic pharmaceutical industry have argued that a court-issued “gag order” sought by defendants would inhibit the responsibility of attorneys general to keep the public informed.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is a leading global provider of competition law, regulation and enforcement information, combining data, deep market insight and a user-centric platform to provide our clients with powerful legal solutions.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10